<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04478214</url>
  </required_header>
  <id_info>
    <org_study_id>MountainDermatology</org_study_id>
    <nct_id>NCT04478214</nct_id>
  </id_info>
  <brief_title>The Strategic Use of Hyaluronic Acid Fillers and Neurotoxin to Influence Gender Perception in Transgender Individuals</brief_title>
  <official_title>The Strategic Use of Hyaluronic Acid Fillers and Neurotoxin to Influence Gender Perception in Transgender Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mountain Dermatology Specialists</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mountain Dermatology Specialists</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational survey study of transgender individuals who have undergone cosmetic neurotoxin
      and soft tissue filler for the purpose of influencing gender perception.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 13, 2019</start_date>
  <completion_date type="Actual">July 15, 2020</completion_date>
  <primary_completion_date type="Actual">July 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Self perceived gender perception</measure>
    <time_frame>4 weeks</time_frame>
    <description>subject reported gender perception on a novel Self-perceived gender perception scale, before and after previously conducted cosmetic treatments. The scale exists on a spectrum of 100% male to 100% female in appearance. Pt will rate themselves along this scale in accordance with their physical appearance as it relates to self-perceived gender.</description>
  </primary_outcome>
  <enrollment type="Actual">2</enrollment>
  <condition>Gender Dysphoria</condition>
  <eligibility>
    <study_pop>
      <textblock>
        2 healthy transgender volunteers age 18-65, of any skin type, with the desire to alter
        gender perception, and are already scheduled for standard of care treatments will be
        enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male or female transgender volunteer

          -  Has the desire to alter gender perception and is seeking treatment with neurotoxin and
             soft tissue filler

          -  Subjects with an already existing treatment plan

          -  Willing to sign photography release, with the understanding the de-identified
             photographs may be used in medical publications or presentations for the purposes of
             education

          -  Females of childbearing potential who are sexually active are using a reliable method
             of contraception1 at least one month before the beginning of the study, and throughout
             the study

          -  Must be informed about the study objectives and procedures, and be able to understand
             them

          -  Willing and able to fulfill the study requirements and schedule

          -  Willing to give their written informed consent

        Exclusion Criteria:

          -  Individuals who underwent a neurotoxin procedure on the face within 6 months of study
             start

          -  Individuals who underwent an injectable filler procedure on the face within 1 year of
             study start

          -  Individuals who underwent surgical procedure on the face for the purpose of gender
             reassignment or cosmetic enhancement at any point in time before study start
             Individuals who have planned cosmetic treatments or surgeries during the course of the
             study

          -  Individuals with dental procedures performed 30 days before, during, or 30 days after
             the course of the study

          -  Individuals who participated within the 30 days before inclusion or currently
             participating in another clinical study involving the investigational areas

          -  Individuals with known or suspected defect of healing

          -  Individuals with any disease state or inappropriate physical skin condition that might
             impair evaluations or increase the health risk to the subject by participation in the
             opinion of the Investigator

          -  Individuals unable to be contacted by phone in case of emergency

          -  Individuals who are currently participating in any other clinical trial or have
             participated in any clinical trial involving the investigation area within 30 days
             prior to inclusion into the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lauren Bonati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Skin Care Physicians</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Skin Care Physicians</name>
      <address>
        <city>Chestnut Hill</city>
        <state>Massachusetts</state>
        <zip>02467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 16, 2019</study_first_submitted>
  <study_first_submitted_qc>July 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2020</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mountain Dermatology Specialists</investigator_affiliation>
    <investigator_full_name>Lauren Bonati</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gender Dysphoria</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

